Tandem Diabetes Care (TNDM) Debt to Equity (2013 - 2025)
Tandem Diabetes Care posted quarterly Debt to Equity of $0.26 for Q1 2025, up 69.7% on a QoQ basis from $0.15 in Q4 2024.
Tandem Diabetes Care (TNDM) has 8 years of Debt to Equity data on file, last reported at $0.26 in Q1 2025.
- For the quarter ending Q1 2025, Debt to Equity changed N/A year-over-year to $0.26; the trailing twelve-month figure through Mar 2025 stood at $0.26 (changed N/A YoY), and the FY2024 full-year result was $0.15, changed N/A from the prior year.
- Debt to Equity for Q1 2025 stood at $0.26, up from $0.15 in the prior quarter.
- Across five years, Debt to Equity topped out at $0.26 in Q1 2025 and bottomed at $0.15 in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt/Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 0.65 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 0.64 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 0.57 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 0.42 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 0.06 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 0.95 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 0.27 |
| 10 | Tandem Diabetes Care | 1.31 Bn | 739.55 Mn | 136.79 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 0.26 |
| Dec 31, 2024 | 0.15 |
| Sep 30, 2024 | 0.17 |
| Jun 30, 2024 | 0.17 |
| Jun 30, 2018 | 2.96 |
| Mar 31, 2018 | 6.45 |
| Dec 31, 2017 | -2.63 |
| Sep 30, 2017 | -2.70 |
| Jun 30, 2017 | -4.09 |
| Mar 31, 2017 | -39.49 |
| Dec 31, 2016 | -13.32 |
| Sep 30, 2016 | 8.60 |
| Jun 30, 2016 | 1.38 |
| Mar 31, 2016 | 0.96 |
| Dec 31, 2015 | 0.46 |
| Sep 30, 2015 | 0.41 |
| Jun 30, 2015 | 0.34 |
| Mar 31, 2015 | 0.29 |
| Dec 31, 2014 | 0.54 |
| Dec 31, 2013 | 0.25 |